Equillium, Inc.

EQNasdaq· Pharmaceutical Preparations

Price History

Revenue

$41.1M

▲ 13.9% YoY

Net Income

-$8.1M

▲ 39.5% YoY

EPS

$-0.23

▲ 39.5% YoY

Cash

$18.1M

▼ 22.1% YoY

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.